SCHEMBL4669271

SCHEMBL4669271

Cc1[nH]c2c(F)ccc(C)c2c1CCNC(=O)/C=C/c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
LMNA P02545 3/20 0.44
ALDH1A1 P00352 2/20 0.44
POLB P06746 2/20 0.43
MAPT P10636 2/20 0.43
NLRP3 Q96P20 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 1/20 0.42
MMP1 P03956 2/20 0.42
MMP2 P08253 2/20 0.42
MMP9 P14780 2/20 0.42
RECQL P46063 1/20 0.42
NDUFS8 O00217 1/20 0.41
COXFA4 O00483 1/20 0.41
NDUFAB1 O14561 1/20 0.41
NDUFA1 O15239 1/20 0.41
NDUFS4 O43181 1/20 0.41
NDUFB5 O43674 1/20 0.41
NDUFB3 O43676 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4754381 1.00 KMT2A (0.47) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL4017825 0.92 MMP1 (0.50) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL4015557 0.90 POLB (0.49) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL4015555 0.90 POLB (0.49) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL4017819 0.88 MEN1 (0.47) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL4017820 0.87 MAPT (0.50) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL4017823 0.87 MAPT (0.50) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL4014345 0.87 MMP1 (0.48) KMT2AMEN1MMP1MMP2MMP9
SCHEMBL4670737 0.86 HDAC4 (0.46) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL4016316 0.86 MEN1 (0.43) KMT2AMEN1LMNAALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008152097-A1 CINNAMIC ACID DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 WO claimed
EP-2003118-A1 Cinnamic acid derivatives as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP claimed
WO-2008152097-A1 CINNAMIC ACID DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 WO disclosed
WO-2008152097-A1 CINNAMIC ACID DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 WO disclosed
EP-2003118-A1 Cinnamic acid derivatives as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP disclosed
EP-2003118-A1 Cinnamic acid derivatives as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP disclosed